MOMP, cell suicide as a BCL-2 family business

Cell Death and Differentiation

Volumn 25, Issue 1, 2018, Pages 46-55

  Kalkavan, Halime ^a   Green, Douglas R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; HEME; MEMBRANE PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; APOPTOSIS REGULATORY PROTEIN; MITOCHONDRIAL PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL FATE; CELL STRESS; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME DEGRADATION; HOMEOSTASIS; HUMAN; MALIGNANT NEOPLASM; MEMBRANE PERMEABILITY; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; ANIMAL; CELL MEMBRANE PERMEABILITY; METABOLISM; MITOCHONDRIAL MEMBRANE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 85046023994     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2017.179     Document Type: Article

References (123)

1. Green DR. The cell's dilemma, or the story of cell death: An entertainment in three acts. FEBS J 2016; 283: 2568-2576.
2. Green DR, Llambi F. Cell death signaling. Cold Spring Harb Perspect Biol 2015; 7: 1-24.
3. Dickens LS, Powley IR, Hughes MA, MacFarlane M. The 'complexities' of life and death: Death receptor signalling platforms. Exp Cell Res 2012; 318: 1269-1277.
4. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
5. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14: 6136.
6. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
7. Crawford ED, Wells JA. Caspase substrates and cellular remodeling. Annu Rev Biochem 2011; 80: 1055-1087.
8. Devreotes P, Horwitz AR. Signaling networks that regulate cell migration. Cold Spring Harb Perspect Biol 2015; 7: A005959.
9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
10. Ichim G, Tait SWG. A fate worse than death: Apoptosis as an oncogenic process. Nat Rev Cancer 2016; 16: 539-548.
11. Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 2009; 460: 1035-1039.
12. Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 2017; 16: 273-284.
13. Billard C. BH3 mimetics: Status of the field and new developments. Mol Cancer Ther 2013; 12: 1691-1700.
14. Aouacheria A, Combet C, Tompa P, Hardwick JM. Redefining the BH3 death domain as a 'short linear motif'. Trends Biochem Sci 2015; 40: 736-748.
15. Bhola PD, Letai A. Mitochondria - judges and executioners of cell death sentences. Mol Cell 2016; 61: 695-704.
16. Letai AG. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 2008; 8: 121-132.
17. Bhola PD, Mar BG, Lindsley RC, Ryan JA, Hogdal LJ, Vo TT et al. Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia. J Clin Invest 2016; 126: 3827-3836.
18. Walther DM, Rapaport D. Biogenesis of mitochondrial outer membrane proteins. Biochim Biophys Acta 2009; 1793: 42-51.
19. Tait SW, Green DR. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
20. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2000; 2: 156-162.
21. Goldstein JC, Munoz-Pinedo C, Ricci JE, Adams SR, Kelekar A, Schuler M et al. Cytochrome c is released in a single step during apoptosis. Cell Death Differ 2005; 12: 453-462.
22. Rehm M, Huber HJ, Hellwig CT, Anguissola S, Dussmann H, Prehn JH. Dynamics of outer mitochondrial membrane permeabilization during apoptosis. Cell Death Differ 2009; 16: 613-623.
23. Bhola PD, Mattheyses AL, Simon SM. Spatial and temporal dynamics of mitochondrial membrane permeability waves during apoptosis. Biophys J 2009; 97: 2222-2231.
24. Garcia-Perez C, Roy SS, Naghdi S, Lin X, Davies E, Hajnoczky G. Bid-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proc Natl Acad Sci USA 2012; 109: 4497-4502.
25. Oberst A, Ichim G, Tait SWG. Mitochondrial permeabilization: From lethality to vitality. In: Hockenbery DM (ed). Mitochondria and Cell Death, Springer Science Business Media, New York, USA, 2016, pp 213-226.
26. Martinou I, Desagher S, Eskes R, Antonsson B, Andre E, Fakan S et al. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J Cell Biol 1999; 144: 883-889.
27. Deshmukh M, Johnson EM Jr. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 1998; 21: 695-705.
28. Tait SW, Parsons MJ, Llambi F, Bouchier-Hayes L, Connell S, Munoz-Pinedo C et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev Cell 2010; 18: 802-813.
29. Monian P, Jiang X. Clearing the final hurdles to mitochondrial apoptosis: Regulation post cytochrome C release. Exp Oncol 2012; 34: 185-191.
30. Jia L, Srinivasula SM, Liu FT, Newland AC. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 2001; 98: 414-421.
31. Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell 2015; 57: 860-872.
32. Liu X, He Y, Li F, Huang Q, Kato TA, Hall RP et al. Caspase-3 promotes genetic instability and carcinogenesis. Mol Cell 2015; 58: 284-296.
33. Julien O, Wells JA. Caspases and their substrates. Cell Death Differ 2017; 24: 1380-1389.
34. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D et al. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015. Cell Death Differ 2015; 22: 58-73.
35. Tang HL, Tang HM, Fung MC, Hardwick JM. In vivo CaspaseTracker biosensor system for detecting anastasis and non-apoptotic caspase activity. Sci Rep 2015; 5: 9015.
36. Tang HL, Tang HM, Mak KH, Hu S, Wang SS, Wong KM et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell 2012; 23: 2240-2252.
37. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.
38. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M et al. Apoptosis and cancer: Mutations within caspase genes. J Med Genet 2009; 46: 497-510.
39. Labi V, Erlacher M. How cell death shapes cancer. Cell Death Dis 2015; 6: E1675.
40. Hars ES, Lyu YL, Lin CP, Liu LF. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res 2006; 66: 8975-8979.
41. Huang Q, Li F, Liu X, Li W, Shi W, Liu FF et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011; 17: 860-866.
42. Munoz-Pinedo C, Guio-Carrion A, Goldstein JC, Fitzgerald P, Newmeyer DD, Green DR. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc Natl Acad Sci USA 2006; 103: 11573-11578.
43. Kulikov AV, Shilov ES, Mufazalov IA, Gogvadze V, Nedospasov SA, Zhivotovsky B. Cytochrome c: The Achilles' heel in apoptosis. Cell Mol Life Sci 2012; 69: 1787-1797.
44. O'Brien ES, Nucci NV, Fuglestad B, Tommos C, Wand AJ. Defining the apoptotic trigger: The interaction of cytochrome c and cardiolipin. J Biol Chem 2015; 290: 30879-30887.
45. Dingeldein APG, Pokorna S, Lidman M, Sparrman T, Sachl R, Hof M et al. Apoptotic Bax at oxidatively stressed mitochondrial membranes: Lipid dynamics and permeabilization. Biophys J 2017; 112: 2147-2158.
46. Ascenzi P, Coletta M, Wilson MT, Fiorucci L, Marino M, Polticelli F et al. Cardiolipin- cytochrome c complex: Switching cytochrome c from an electron-transfer shuttle to a myoglobin- and a peroxidase-like heme-protein. IUBMB Life 2015; 67: 98-109.
47. Mandal A, Hoop CL, DeLucia M, Kodali R, Kagan VE, Ahn J et al. Structural changes and proapoptotic peroxidase activity of cardiolipin-bound mitochondrial cytochrome c. Biophys J 2015; 109: 1873-1884.
48. Sharma GS, Singh LR. Conformational status of cytochrome c upon N-homocysteinylation: Implications to cytochrome c release. Arch Biochem Biophys 2017; 614: 23-27.
49. Mara MW, Hadt RG, Reinhard ME, Kroll T, Lim H, Hartsock RW et al. Metalloprotein entatic control of ligand-metal bonds quantified by ultrafast x-ray spectroscopy. Science 2017; 356: 1276-1280.
50. McClelland LJ, Steele HB,Whitby FG,Mou TC, Holley D, Ross JB et al. Cytochrome c can form a well-defined binding pocket for hydrocarbons. J Am Chem Soc 2016; 138: 16770-16778.
51. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 2005; 1: 223-232.
52. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 2002; 99: 1259-1263.
53. Große L, Wurm CA, Brüser C, Neumann D. Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis. EMBO J 2016; 35: 402-413.
54. Oettinghaus B, D'Alonzo D, Barbieri E, Restelli LM, Savoia C, Licci M et al. DRP1-dependent apoptotic mitochondrial fission occurs independently of BAX, BAK and APAF1 to amplify cell death by BID and oxidative stress. Biochim Biophys Acta 2016; 1857: 1267-1276.
55. Estaquier J, Arnoult D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ 2007; 14: 1086-1094.
56. Malin JZ, Shaham S. Cell death in C. elegans development. Curr Top Dev Biol 2015; 114: 1-42.
57. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: Functions beyond respiration. Nat Rev Mol Cell Biol 2008; 9: 532-542.
58. Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y et al. Caspase-9: Structure, mechanisms and clinical application. Oncotarget 2017; 8: 23996-24008.
59. Lakhani SA, Masud A, Kuida K, Porter GA Jr., Booth CJ, Mehal WZ et al. Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis. Science 2006; 311: 847-851.
60. Du CY, Fang M, Li YC, Li L, Wang XD. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.
61. Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 2000; 408: 1004-1008.
62. Berthelet J, Dubrez L. Regulation of apoptosis by inhibitors of apoptosis (IAPs). Cells 2013; 2: 163-187.
63. Saita S, Nolte H, Fiedler KU, Kashkar H, Venne AS, Zahedi RP et al. PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis. Nat Cell Biol 2017; 19: 318-328.
64. Bai LC, Smith DC, Wang SM. Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol Ther 2014; 144: 82-95.
65. Fulda S. Promises and challenges of Smac mimetics as cancer therapeutics. Clin Cancer Res 2015; 21: 5030-5036.
66. Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov 2012; 11: 109-124.
67. He GW, Gunther C, Thonn V, Yu YQ, Martini E, Buchen B et al. Regression of apoptosisresistant colorectal tumors by induction of necroptosis in mice. J Exp Med 2017; 214: 1655-1662.
68. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8: 613-621.
69. van Loo G, Gurp VM, Depuydt B. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002; 9: 20-26.
70. Walle LV, Lamkanfi M. The mitochondrial serine protease HtrA2/Omi: An overview. Cell Death Differ 2008; 15: 453-460.
71. Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007; 129: 983-997.
72. Haraguchi M, Torii S, Matsuzawa S, Xie Z, Kitada S, Krajewski S et al. Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J Exp Med 2000; 191: 1709-1720.
73. Shamas-Din A, Kale J, Leber B, Andrews DW. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol 2013; 5: A008714.
74. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730.
75. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005; 19: 1294-1305.
76. Hsu Y-T, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 1997; 94: 3668-3672.
77. Czabotar PE, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD et al. Bax crystal structures reveal how BH3 domains activate bax and nucleate its oligomerization to induce apoptosis. Cell 2013; 152: 519-531.
78. Brouwer JM, Westphal D, Dewson G, Robin AY, Uren RT, Bartolo R et al. Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers. Mol Cell 2014; 55: 938-946.
79. Landeta O, Landajuela A, Gil D, Taneva S, Di Primo C, Sot B et al. Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process. J Biol Chem 2011; 286: 8213-8230.
80. Birkinshaw RW, Czabotar PE. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation. Semin Cell Dev Biol 2017. (http://dx.doi.org/10.1016/j. semcdb.2017.04.001).
81. Gahl RF, Dwivedi P, Tjandra N. Bcl-2 proteins bid and bax form a network to permeabilize the mitochondria at the onset of apoptosis. Cell Death Dis 2016; 7: E2424.
82. Korsmeyer SJ, Gross A, Harada H, Zha J,Wang K, Yin XM et al. Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. Cold Spring Harb Symp Quant Biol 1999; 64: 343-350.
83. Shamas-Din A, Satsoura D, Khan O, Zhu W, Leber B, Fradin C et al. Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid. Cell Death Dis 2014; 5: E1277.
84. Subburaj Y, Cosentino K, Axmann M, Pedrueza-Villalmanzo E, Hermann E, Bleicken S et al. Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species. Nat Commun 2015; 6: 8042.
85. Oh KJ, Singh P, Lee K, Foss K, Lee S, Park M et al. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J Biol Chem 2010; 285: 28924-28937.
86. Pang YP, Dai HM, Smith A, Meng XW, Schneider PA, Kaufmann SH. Bak conformational changes induced by ligand binding: Insight into BH3 domain binding and Bak homooligomerization. Scientific Rep 2012; 2: 257.
87. Bleicken S, Jeschke G, Stegmueller C, Salvador-Gallego R, Garcia-Saez AJ, Bordignon E. Structural model of active Bax at the membrane. Mol Cell 2014; 56: 496-505.
88. Tait SWG, Green DR. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
89. Dewson G, Kratina T, Sim HW, Puthalakath H, Adams JM, Colman PM et al. To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: Groove interactions. Mol Cell 2008; 30: 369-380.
90. Zhang M, Zheng J, Nussinov R, Ma B. Release of cytochrome C from Bax pores at the mitochondrial membrane. Sci Rep 2017; 7: 2635.
91. Schafer B, Quispe J, Choudhary V, Chipuk JE, Ajero TG, Du H et al. Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation. Mol Biol Cell 2009; 20: 2276-2285.
92. Garcia-Saez AJ. The secrets of the Bcl-2 family. Cell Death Differ 2012; 19: 1733-1740.
93. Gillies LA, Du H, Peters B, Knudson CM, Newmeyer DD, Kuwana T. Visual and functional demonstration of growing Bax-induced pores in mitochondrial outer membranes. Mol Biol Cell 2015; 26: 339-349.
94. Hsu SY, Kaipia A, McGee E, Lomeli M, Hsueh AJW. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 1997; 94: 12401-12406.
95. Inohara N, Ekhterae D, Garcia I, Carrio R, Merino J, Merry A et al. Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL. J Biol Chem 1998; 273: 8705-8710.
96. Hsu SY, Kaipia A, McGee E. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 1997; 94: 12401-12406.
97. Llambi F, Wang YM, Victor B, Yang M, Schneider DM, Gingras S et al. BOK is a noncanonical BCL-2 family effector of apoptosis regulated by ER-associated degradation. Cell 2016; 165: 421-433.
98. Ke F, Voss A, Kerr JB, O'Reilly LA, Tai L, Echeverry N et al. BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice. Cell Death Differ 2012; 19: 915-925.
99. Echeverry N, Bachmann D, Ke F, Strasser A, Simon HU, Kaufmann T. Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ 2013; 20: 785-799.
100. Carpio MA, Michaud M, Zhou W, Fisher JK, Walensky LD, Katz SG. BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress. Proc Natl Acad Sci USA 2015; 112: 7201-7206.
101. Fernandez-Marrero Y, Ke F, Echeverry N, Bouillet P, Bachmann D, Strasser A et al. Is BOK required for apoptosis induced by endoplasmic reticulum stress?. Proc Natl Acad Sci USA 2016; 113: E492-E493.
102. Einsele-Scholz S, Malmsheimer S, Bertram K, Stehle D, Johanning J, Manz M et al. Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak. J Cell Sci 2016; 129: 2213-2223.
103. Schulman JJ, Wright FA, Han X, Zluhan EJ, Szczesniak LM, Wojcikiewicz RJ. The stability and expression level of bok are governed by binding to inositol 1,4,5-trisphosphate receptors. J Biol Chem 2016; 291: 11820-11828.
104. Schulman JJ, Wright FA, Kaufmann T, Wojcikiewicz RJ. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage. J Biol Chem 2013; 288: 25340-25349.
105. Fernandez-Marrero Y, Bleicken S, Das KK, Bachmann D, Kaufmann T, Garcia-Saez AJ. The membrane activity of BOK involves formation of large, stable toroidal pores and is promoted by cBID. FEBS J 2017; 284: 711-724.
106. O'Neill KL, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev 2016; 30: 973-988.
107. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 2012; 148: 988-1000.
108. Birbes H, Luberto C, Yi-Te HSU, Bawab ES. Amitochondrial pool of sphingomyelin is involved in TNFα-induced Bax translocation to mitochondria. Biochemical 2005; 386(Part 3): 445-451.
109. Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008; 135: 1074-1084.
110. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell 2011; 44: 517-531.
111. Landeta O, Landajuela A, Garcia-Saez A, Basanez G. Minimalist model systems reveal similarities and differences between membrane interaction modes of MCL1 and BAK. J Biol Chem 2015; 290: 17004-17019.
112. Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C et al. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell 2011; 145: 104-116.
113. Todt F, Cakir Z, Reichenbach F, Emschermann F, Lauterwasser J, Kaiser A et al. Differential retrotranslocation of mitochondrial Bax and Bak. EMBO J 2015; 34: 67-80.
114. Schellenberg B, Wang PB, Keeble JA, Rodriguez-Enriquez R, Walker S, Owens TW et al. Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming. Mol Cell 2013; 49: 959-971.
115. Andreu-Fernandez V, Sancho M, Genoves A, Lucendo E, Todt F, Lauterwasser J et al. Bax transmembrane domain interacts with prosurvival Bcl-2 proteins in biological membranes. Proc Natl Acad Sci USA 2017; 114: 310-315.
116. Garner TP, Reyna DE, Priyadarshi A, Chen HC, Li S, Wu Y et al. An autoinhibited dimeric form of BAX regulates the BAX activation pathway. Mol Cell 2016; 64: 431.
117. Pihán P, Carreras-Sureda A, Hetz C. BCL-2 family: Integrating stress responses at the ER to control cell demise. Cell Death Differ 2017; 24: 1478-1487.
118. Letai A, Bassik MC, Walensky LD, Sorcinelli MD. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183-192.
119. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393-403.
120. Leber B, Lin J, Andrews DW. Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 2007; 12: 897-911.
121. Gavathiotis E, Reyna DE, Davis ML, Bird GH, Walensky LD. BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell 2010; 40: 481-492.
122. Fu NY, Sukumaran SK, Kerk SY, Victor CY. Baxβ: A constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism. Mol Cell 2009; 33: 15-29.
123. Chattopadhyay E, Roy B. Altered mitochondrial signalling and metabolism in cancer. Front Oncol 2017; 7: 43.